이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Chison Medical Technologies 대차 대조표 상태

재무 상태 기준 확인 6/6

Chison Medical Technologies 의 총 주주 지분은 CN¥1.4B 이고 총 부채는 CN¥0.0, 이는 부채 대 자기자본 비율을 0% 로 가져옵니다. 총자산과 총부채는 각각 CN¥1.5B 및 CN¥122.7M 입니다. Chison Medical Technologies 의 EBIT는 CN¥98.6M 이며 이자보상배율은 -3.2 입니다. CN¥1.1B 의 현금 및 단기 투자금을 보유하고 있습니다.

주요 정보

부채 비율

CN¥0

부채

이자 보상 비율	-3.2x
현금	CN¥1.06b
주식	CN¥1.42b
총 부채	CN¥122.66m
총 자산	CN¥1.54b

최근 재무 상태 업데이트

업데이트 없음

Recent updates

Chison Medical Technologies' (SHSE:688358) Solid Earnings May Rest On Weak Foundations

Apr 25

Further Upside For Chison Medical Technologies Co., Ltd. (SHSE:688358) Shares Could Introduce Price Risks After 27% Bounce

Mar 04

재무 상태 분석

단기부채: 688358 의 단기 자산 ( CN¥1.4B )이 단기 부채( CN¥108.1M ).

장기 부채: 688358 의 단기 자산( CN¥1.4B )이 장기 부채( CN¥14.5M ).

부채 대 자본 내역 및 분석

부채 수준: 688358 부채가 없습니다.

부채 감소: 688358 지난 5년간 부채가 없습니다.

부채 범위: 688358 은 부채가 없으므로 영업현금흐름으로 충당할 필요가 없습니다.

이자 보장: 688358 에는 부채가 없으므로 이자 지불에 대한 보장은 문제가 되지 않습니다.

Chison Medical Technologies 대차 대조표 상태

재무 상태 기준 확인 6/6

주요 정보

최근 재무 상태 업데이트

Recent updates

Chison Medical Technologies Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024

Chison Medical Technologies' (SHSE:688358) Solid Earnings May Rest On Weak Foundations

First quarter 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.47 in 1Q 2023)

Chison Medical Technologies Co., Ltd., Annual General Meeting, May 10, 2024

Now 21% undervalued after recent price drop

Chison Medical Technologies Co., Ltd. to Report Q1, 2024 Results on Apr 19, 2024

Investor sentiment improves as stock rises 18%

Further Upside For Chison Medical Technologies Co., Ltd. (SHSE:688358) Shares Could Introduce Price Risks After 27% Bounce

Now 23% undervalued after recent price drop

Full year 2023 earnings: EPS and revenues miss analyst expectations

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 17%

Now 20% undervalued after recent price drop

Investor sentiment improves as stock rises 17%

Third quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.44 in 3Q 2022)

Chison Medical Technologies Co., Ltd. (SHSE:688358) commences an Equity Buyback for CNY 20 million worth of its shares, under the authorization approved on September 12, 2023.

Second quarter 2023 earnings released: EPS: CN¥0.53 (vs CN¥0.46 in 2Q 2022)

Chison Medical Technologies Co., Ltd. to Report First Half, 2023 Results on Aug 29, 2023

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 31%

First quarter 2023 earnings released: EPS: CN¥0.47 (vs CN¥0.22 in 1Q 2022)

Third quarter 2022 earnings released: EPS: CN¥0.44 (vs CN¥0.27 in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.46 (vs CN¥0.22 in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

First quarter 2022 earnings released: EPS: CN¥0.31 (vs CN¥0.28 in 1Q 2021)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.38 (vs CN¥0.33 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.31 (vs CN¥0.27 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.28 (vs CN¥0.22 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥1.32 (vs CN¥1.70 in FY 2019)

New 90-day low: CN¥49.00

New 90-day low: CN¥54.52

New 90-day low - CN¥61.94

New 90-day low - CN¥67.90

Chison Medical Technologies Co., Ltd. to Report First Half, 2020 Results on Aug 29, 2020

재무 상태 분석

부채 대 자본 내역 및 분석

대차 대조표

건강한 기업 발견하기